Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Metarrestin |
Synonyms | |
Therapy Description |
Metarrestin is a small molecule drug that inhibits the assembly of the perinucleolar compartment, leading to disruption of the nucleolar structure and inhibition of RNA polymerase I transcription, which may result in decreased metastasis, including reduced cell growth and invasion and decreased tumor growth (PMID: 29769289). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Metarrestin | ML-246|ML 246|ML246 | Metarrestin is a small molecule drug that inhibits the assembly of the perinucleolar compartment, leading to disruption of the nucleolar structure and inhibition of RNA polymerase I transcription, which may result in decreased metastasis, including reduced cell growth and invasion and decreased tumor growth (PMID: 29769289). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT04222413 | Phase I | Metarrestin | Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors | Recruiting | USA | 0 |